Form 8-K - Current report:
SEC Accession No. 0001935979-25-000080
Filing Date
2025-08-22
Accepted
2025-08-22 06:59:15
Documents
12
Period of Report
2025-08-21
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20250821.htm   iXBRL 8-K 19915
  Complete submission text file 0001935979-25-000080.txt   133681

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20250821.xsd EX-101.SCH 1803
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20250821_lab.xml EX-101.LAB 21597
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20250821_pre.xml EX-101.PRE 12510
15 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20250821_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 251242175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)